<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Marshall | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/windowpound31/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/windowpound31/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Marshall.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">ec00a44b018407c0251066ffbb65d7d9</guid>
				<title>Marshall posted an update: e associated with a low bleeding risk. Our data support [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42525/</link>
				<pubDate>Sun, 09 Feb 2025 09:49:50 -0800</pubDate>

									<content:encoded><![CDATA[<p>e associated with a low bleeding risk. Our data support consideration of a 2-4 week trial of antithrombotic therapy, usually starting with antiplatelet therapy, in aPL-positive patients with refractory migraine, particularly if other treatment options have been exhausted. As a retrospective study, our data provide only Class IV level of e&hellip;<span class="activity-read-more" id="activity-read-more-42525"><a href="http://www.nationalboardinstitute.com/activity/p/42525/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bf49ca37f28111d3e8c7fc577746866c</guid>
				<title>Marshall posted an update: Although benzophenone-3 seemed protective on low-fat diet, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40828/</link>
				<pubDate>Fri, 07 Feb 2025 09:30:45 -0800</pubDate>

									<content:encoded><![CDATA[<p>Although benzophenone-3 seemed protective on low-fat diet, spindle cell tumors arising in these mice showed increased proliferation and decreased apoptosis. This points to a need for further studies of benzophenone-3 in both animal models and humans as a potential breast cancer risk factor, as well as a more general need to evaluate endocrine&hellip;<span class="activity-read-more" id="activity-read-more-40828"><a href="http://www.nationalboardinstitute.com/activity/p/40828/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">be124c2ed4185eb8836d7d3c4112cabe</guid>
				<title>Marshall posted an update: Approximately 30% of patients experience nausea after [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33468/</link>
				<pubDate>Thu, 30 Jan 2025 09:29:41 -0800</pubDate>

									<content:encoded><![CDATA[<p>Approximately 30% of patients experience nausea after initiation of opioid therapy, which can lead to poor quality of life. We aimed to identify risk factors for opioid-induced nausea at the initiation of opioid therapy by conducting a retrospective review of medical records of patients diagnosed by palliative care specialists with solid cancer&hellip;<span class="activity-read-more" id="activity-read-more-33468"><a href="http://www.nationalboardinstitute.com/activity/p/33468/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5fc6af56e8c705b8d609208bafc5a7e8</guid>
				<title>Marshall posted an update: Please see http//www.annualreviews.org/page/journal/pubdates [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29164/</link>
				<pubDate>Tue, 28 Jan 2025 12:54:20 -0800</pubDate>

									<content:encoded><![CDATA[<p>Please see http//www.annualreviews.org/page/journal/pubdates for revised estimates.Purpose This study aims to explore the physical, psychological and social wellbeing of veterans who have experienced limb-loss and to ascertain the factors that contribute to the ability of veterans to maintain their independence at various stages in their&hellip;<span class="activity-read-more" id="activity-read-more-29164"><a href="http://www.nationalboardinstitute.com/activity/p/29164/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2262dd17e7c62518c89f9103039a4ee7</guid>
				<title>Marshall became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29129/</link>
				<pubDate>Tue, 28 Jan 2025 12:52:20 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>